（代表性5篇）
1. Yunxin Lai#, Jianyu Weng#, Xinru Wei, Le Qin, Peilong Lai, Ruocong Zhao, Zhiwu Jiang, Baiheng Li, Simiao Lin, Suna Wang, Qiting Wu, Zhaoyang Tang, Pentao liu, Duanqing Pei, Yao Yao, Xin Du*, and Peng Li*. Toll-like Receptor 2 Costimulation Potentiates the Antitumor Efficacy of CAR T Cells. Leukemia. 2018, 32(3): 801-808.
2. Lv J#, Zhao R#, Wu D#, Zheng D, Wu Z, Shi J, Wei X, Wu Q, Long Y, Lin S, Wang S, Wang Z, Li Y, Chen Y, He Q, Chen S, Yao H, Liu Z, Tang Z, Yao Y, Pei D, Liu P, Zhang X, Zhang Z, Cui S, Chen R, Peng Li*. Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer. J Hematol Oncol. 2019, 12(1): 18.
3. W Li, ZW Jiang, TZ Li, X Wei, Yi Zheng, D Wu, L Yang, S Chen, B Xu, M Zhong, J Jiang, Y Hu, H Su, M Zhang, X Huang, S Geng, J Weng, X Du, P Liu, Y Li, H Liu, Yao Yao* and Peng Li*. Genome-wide analyses identify KLF4 as an important negative regulator in T-cell acute lymphoblastic leukemia through directly inhibiting T-cell associated genes. Molecular Cancer. 2015, 14: 26.
4. Xiao Y, Jiang Z, Li Y, Ye W, Jia B, Zhang M, Xu Y, Wu D, Lai L, Chen Y, Chang Y, Huang X, Liu H, Qing G, Liu P, Li Y, Xu B, Zhong M, Yao Y, Pei D, Peng Li*. ANGPTL7 regulates the expansion and repopulation of human hematopoietic stem and progenitor cells. Haematologica. 2015, 100 (5): 585-594.
5. Peng Li, Burke S et al, Liu P*. Reprogramming of T Cells to Natural Killer-Like Cells upon Bcl11b Deletion. Science. 2010, 329(5987): 85-89.
